Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adjusted CT Image-Based Radiomic Features Combined with Immune Genomic Expression Achieve Accurate Prognostic Classification and Identification of Therapeutic Targets in Stage III Colorectal Cancer. | Cancers (Basel) | 2022 | 35454802 | PubTator, text mining | PubMed |
| Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITL. | PLoS Pathog | 2022 | 35452490 | PubTator, text mining | PubMed |
| Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib. | Ther Adv Hematol | 2022 | 35450208 | PubTator, text mining | PubMed |
| Immune and epithelial determinants of age-related risk and alveolar injury in fatal COVID-19. | JCI Insight | 2022 | 35446789 | PubTator, text mining | PubMed |
| Circulating T regulatory cell subsets in patients with untreated lung cancer. | Clin Transl Oncol | 2022 | 35445283 | PubTator, text mining | PubMed |
| Combined therapy with CD4+ CD25highCD127- T regulatory cells and anti-CD20 antibody in recent-onset type 1 diabetes is superior to monotherapy: Randomized phase I/II trial. | Diabetes Obes Metab | 2022 | 35441440 | PubTator, text mining | PubMed |
| The Association between Regulatory T Cell Subpopulations and Severe Pneumonia Post Renal Transplantation. | J Immunol Res | 2022 | 35437510 | PubTator, text mining | PubMed |
| Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target. | Elife | 2022 | 35437144 | PubTator, text mining | PubMed |
| Identification and Validation of Hub Genes with Poor Prognosis in Hepatocellular Carcinoma by Integrated Bioinformatical Analysis. | Int J Gen Med | 2022 | 35431572 | PubTator, text mining | PubMed |
| Membrane marker selection for segmenting single cell spatial proteomics data. | Nat Commun | 2022 | 35422106 | PubTator, text mining | PubMed |
| Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infection. | Cell Rep | 2022 | 35421379 | PubTator, text mining | PubMed |
| Prolonged viral suppression with anti-HIV-1 antibody therapy. | Nature | 2022 | 35418681 | PubTator, text mining | PubMed |
| Omics-based biomarkers for diagnosis and prediction of kidney allograft rejection. | Korean J Intern Med | 2022 | 35417937 | PubTator, text mining | PubMed |
| Selective hypermethylation is evident in small intestine samples from infants with necrotizing enterocolitis. | Clin Epigenetics | 2022 | 35410447 | PubTator, text mining | PubMed |
| YAP Transcriptional Activity Dictates Cell Response to TNF In Vitro. | Front Immunol | 2022 | 35401557 | PubTator, text mining | PubMed |
| Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer. | Front Immunol | 2022 | 35401554 | PubTator, text mining | PubMed |
| Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response. | Mol Ther Oncolytics | 2022 | 35399603 | PubTator, text mining | PubMed |
| Tumor-associated CD163+ macrophage as a predictor of tumor spread through air spaces and with CD25+ lymphocyte as a prognostic factor in resected stage I lung adenocarcinoma. | Lung Cancer | 2022 | 35395482 | PubTator, text mining | PubMed |
| LATS1 is a central signal transmitter for achieving full type-I interferon activity. | Sci Adv | 2022 | 35394840 | PubTator, text mining | PubMed |
| Single-cell transcriptomics of the ventral posterolateral nucleus-enriched thalamic regions from HSV-1-infected mice reveal a novel microglia/microglia-like transcriptional response. | J Neuroinflammation | 2022 | 35387656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=51